David Lonergan

Small Molecule Lysyl Oxidase-like 2 (LOXL2) Inhibitors: The Identification of an Inhibitor Selective for LOXL2 over LOX

John H. Hutchinson, Martin W. Rowbottom, David Lonergan et al. · ACS Medicinal Chemistry Letters · 2017 · 82 citations · Full text

Identification of 4-(Aminomethyl)-6-(trifluoromethyl)-2-(phenoxy)pyridine Derivatives as Potent, Selective, and Orally Efficacious Inhibitors of the Copper-Dependent Amine Oxidase, Lysyl Oxidase-Like 2 (LOXL2)

Martin W. Rowbottom, Gretchen Bain, Imelda Calderon et al. · Journal of Medicinal Chemistry · 2017 · 65 citations · Full text

Initial Hit 2, Pharmacotherapy, Chemical Biology +21

Tricyclic scaffolds for the rapid assembly of abiotic receptors

David Lonergan, Ghislain Deslongchamps · Tetrahedron · 1998 · 33 citations

Combinatorial Chemistry, Receptor (Biochemistry), Molecular Biology +2

A convergent hydroxyimide module for molecular recognition

David Lonergan, Juan Riego, Ghislain Deslongchamps · Tetrahedron Letters · 1996 · 25 citations

Molecular Characterization, Engineering, Molecular Biology +4

Comparative probe for stacking interactions in simple A:T base pair mimics

David Lonergan, Jonathan Halse, Ghislain Deslongchamps · Tetrahedron Letters · 1998 · 13 citations

Comparative Probe, Physics, Protein Folding +3